These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30485484)

  • 21. The E3 Ubiquitin Ligase c-Cbl Inhibits Microglia-Mediated CNS Inflammation by Regulating PI3K/Akt/NF-κB Pathway.
    Dong L; Li YZ; An HT; Wang YL; Chen SH; Qian YJ; Wang K; Zhen JL; Fan Z; Gong XL; Zheng Y; Wang XM
    CNS Neurosci Ther; 2016 Aug; 22(8):661-9. PubMed ID: 27156691
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Downregulation of miR-124 in MPTP-treated mouse model of Parkinson's disease and MPP iodide-treated MN9D cells modulates the expression of the calpain/cdk5 pathway proteins.
    Kanagaraj N; Beiping H; Dheen ST; Tay SS
    Neuroscience; 2014 Jul; 272():167-79. PubMed ID: 24792712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The TLR4/NF-κB/NLRP3 and Nrf2/HO-1 pathways mediate the neuroprotective effects of alkaloids extracted from Uncaria rhynchophylla in Parkinson's disease.
    Zhang C; Zhou J; Zhuo L; Zhang W; Lv L; Zhu L; Zhang J; Feng F; Liu W; Han L; Liao W
    J Ethnopharmacol; 2024 May; 333():118391. PubMed ID: 38797377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EriB targeted inhibition of microglia activity attenuates MPP
    Dou F; Chu X; Zhang B; Liang L; Lu G; Ding J; Chen S
    Mol Brain; 2018 Dec; 11(1):75. PubMed ID: 30563578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. α-Asarone attenuates microglia-mediated neuroinflammation by inhibiting NF kappa B activation and mitigates MPTP-induced behavioral deficits in a mouse model of Parkinson's disease.
    Kim BW; Koppula S; Kumar H; Park JY; Kim IW; More SV; Kim IS; Han SD; Kim SK; Yoon SH; Choi DK
    Neuropharmacology; 2015 Oct; 97():46-57. PubMed ID: 25983275
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dl-3-
    Chen Y; Wu T; Li H; Li X; Li Q; Zhu X; Yu M; Kuo SH; Huang F; Wu YC
    Front Aging Neurosci; 2019; 11():44. PubMed ID: 30873019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treadmill exercise produces neuroprotective effects in a murine model of Parkinson's disease by regulating the TLR2/MyD88/NF-κB signaling pathway.
    Koo JH; Jang YC; Hwang DJ; Um HS; Lee NH; Jung JH; Cho JY
    Neuroscience; 2017 Jul; 356():102-113. PubMed ID: 28527958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amentoflavone protects dopaminergic neurons in MPTP-induced Parkinson's disease model mice through PI3K/Akt and ERK signaling pathways.
    Cao Q; Qin L; Huang F; Wang X; Yang L; Shi H; Wu H; Zhang B; Chen Z; Wu X
    Toxicol Appl Pharmacol; 2017 Mar; 319():80-90. PubMed ID: 28185818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced dopaminergic neurotoxicity mediated by MPTP in IL-32β transgenic mice.
    Jung YY; Katila N; Neupane S; Shadfar S; Ojha U; Bhurtel S; Srivastav S; Son DJ; Park PH; Yoon DY; Hong JT; Choi DY
    Neurochem Int; 2017 Jan; 102():79-88. PubMed ID: 27956238
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of Src tyrosine kinase activity by squamosamide derivative FLZ attenuates neuroinflammation in both in vivo and in vitro Parkinson's disease models.
    Tai W; Ye X; Bao X; Zhao B; Wang X; Zhang D
    Neuropharmacology; 2013 Dec; 75():201-12. PubMed ID: 23916477
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Farrerol protects dopaminergic neurons in a rat model of lipopolysaccharide-induced Parkinson's disease by suppressing the activation of the AKT and NF-κB signaling pathways.
    Li Y; Zeng Y; Meng T; Gao X; Huang B; He D; Ran X; Du J; Zhang Y; Fu S; Hu G
    Int Immunopharmacol; 2019 Oct; 75():105739. PubMed ID: 31351366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Isobavachalcone Attenuates MPTP-Induced Parkinson's Disease in Mice by Inhibition of Microglial Activation through NF-κB Pathway.
    Jing H; Wang S; Wang M; Fu W; Zhang C; Xu D
    PLoS One; 2017; 12(1):e0169560. PubMed ID: 28060896
    [TBL] [Abstract][Full Text] [Related]  

  • 33. P7C3 Inhibits LPS-Induced Microglial Activation to Protect Dopaminergic Neurons Against Inflammatory Factor-Induced Cell Death
    Gu C; Hu Q; Wu J; Mu C; Ren H; Liu CF; Wang G
    Front Cell Neurosci; 2018; 12():400. PubMed ID: 30455635
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Idebenone Alleviates Neuroinflammation and Modulates Microglial Polarization in LPS-Stimulated BV2 Cells and MPTP-Induced Parkinson's Disease Mice.
    Yan A; Liu Z; Song L; Wang X; Zhang Y; Wu N; Lin J; Liu Y; Liu Z
    Front Cell Neurosci; 2018; 12():529. PubMed ID: 30687016
    [No Abstract]   [Full Text] [Related]  

  • 35. IL-17A exacerbates neuroinflammation and neurodegeneration by activating microglia in rodent models of Parkinson's disease.
    Liu Z; Qiu AW; Huang Y; Yang Y; Chen JN; Gu TT; Cao BB; Qiu YH; Peng YP
    Brain Behav Immun; 2019 Oct; 81():630-645. PubMed ID: 31351185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of the JAK/STAT Pathway Protects Against α-Synuclein-Induced Neuroinflammation and Dopaminergic Neurodegeneration.
    Qin H; Buckley JA; Li X; Liu Y; Fox TH; Meares GP; Yu H; Yan Z; Harms AS; Li Y; Standaert DG; Benveniste EN
    J Neurosci; 2016 May; 36(18):5144-59. PubMed ID: 27147665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Licochalcone A Prevents the Loss of Dopaminergic Neurons by Inhibiting Microglial Activation in Lipopolysaccharide (LPS)-Induced Parkinson's Disease Models.
    Huang B; Liu J; Ju C; Yang D; Chen G; Xu S; Zeng Y; Yan X; Wang W; Liu D; Fu S
    Int J Mol Sci; 2017 Sep; 18(10):. PubMed ID: 28937602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cordycepin mitigates MPTP-induced Parkinson's disease through inhibiting TLR/NF-κB signaling pathway.
    Cheng C; Zhu X
    Life Sci; 2019 Apr; 223():120-127. PubMed ID: 30790609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Early activation of Egr-1 promotes neuroinflammation and dopaminergic neurodegeneration in an experimental model of Parkinson's disease.
    Yu Q; Huang Q; Du X; Xu S; Li M; Ma S
    Exp Neurol; 2018 Apr; 302():145-154. PubMed ID: 29337144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ginsenoside Rg1 attenuates motor impairment and neuroinflammation in the MPTP-probenecid-induced parkinsonism mouse model by targeting α-synuclein abnormalities in the substantia nigra.
    Heng Y; Zhang QS; Mu Z; Hu JF; Yuan YH; Chen NH
    Toxicol Lett; 2016 Jan; 243():7-21. PubMed ID: 26723869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.